Skip to content
Nurse using the HyperArc machine on patient

Transforming brain tumour treatment with HyperArc

With your generous support, we are able to fund innovative technologies like HyperArc, helping the dedicated team at Guy's Cancer provide advanced precision radiotherapy for brain tumour treatment.

What is HyperArc?

HyperArc is a world class technology that will transform patient experience and improve quality of life by minimising side effects and shortening treatment times.

This ground-breaking technology can advance treatment for brain tumours by offering targeted radiotherapy with unrivalled precision.

Advancing the future in radiotherapy treatment for brain tumours

Brain metastasis occurs when cancer cells from other parts of the body, like the lungs, spread to the brain. Traditionally, treating brain metastasis meant using whole-brain radiation therapy, a treatment that targets the entire brain in an attempt to remove all the cancer cells. However, this method also affects healthy tissue, leading to significant side effects like cognitive impairment, hair loss, and fatigue.

HyperArc represents a breakthrough in treatment for brain tumours. This specialised technology allows doctors to treat only the areas where the tumours are located, delivering high doses of radiation directly to the cancer cells while sparing surrounding healthy tissue. It’s a significant advancement, enabling faster, more effective treatment with fewer side effects.

Nurse using the HyperArc machine on patient

Benefits of HyperArc

One of the biggest benefits of HyperArc is the reduction in the amount of time spent receiving treatment. Previously, patients could spend over an hour lying still on a hard treatment table, often secured with a mask or head clamp. This procedure can be uncomfortable, and many patients need some sedatives to help them stay calm during the process. With HyperArc, the length of treatment is greatly reduced, making it kinder and more inclusive.

Whole brain radiotherapy is usually delivered over several days, but HyperArc allows consistently high accuracy treatment in a single visit. This shorter treatment course means less disruption to patients’ lives and reduces the anxiety that often accompanies long treatment schedules.

Many patients who have disabilities, or claustrophobia, just cannot tolerate this sort of treatment. So, with shorter treatment times of around 15 minutes, we will be able to provide access to this very advanced radiotherapy treatment for patients who currently are unable to access it.

Dr Kazumi Chia, Consultant Clinical Oncologist at Guy’s Cancer

Offering patients a better treatment plan

The precision targeting of HyperArc ensures that radiation is delivered only to the tumour sites, making it possible to treat brain metastasis without affecting other areas of the body. Many people with brain cancer also have secondary tumours elsewhere. HyperArc makes it easier for doctors to carefully sequence treatments, ensuring that the brain metastasis is addressed first before moving on to other cancer sites. This streamlined approach offers patients a better treatment plan that’s both efficient and effective.

Understandably, receiving a cancer diagnosis can be a frightening time, and many patients become anxious and eager to start treatment as soon as possible. HyperArc will allow Guy’s Cancer’s dedicated staff to treat more patients by shortening waiting times for treatment. “Treatment planning will be more efficient, and the treatment delivery will be faster, which means there will be more capacity for staff to be treating other patients in the cancer centre,” Dr Kazumi Chia.

We are proud to support innovative technologies like HyperArc that are transforming the way cancer is treated. By reducing treatment times, minimizing side effects, and improving outcomes, patients can rest assured knowing that they’re receiving the most advanced care without unnecessary discomfort.

Help us push boundaries and provide hope for more patients through innovative treatments like HyperArc by donating today.

£
£